Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach
- PMID: 34346317
- PMCID: PMC8282961
- DOI: 10.1016/j.compbiomed.2021.104654
Investigation of nonsynonymous mutations in the spike protein of SARS-CoV-2 and its interaction with the ACE2 receptor by molecular docking and MM/GBSA approach
Abstract
COVID-19 is an infectious and pathogenic viral disease caused by SARS-CoV-2 that leads to septic shock, coagulation dysfunction, and acute respiratory distress syndrome. The spreading rate of SARS-CoV-2 is higher than MERS-CoV and SARS-CoV. The receptor-binding domain (RBD) of the Spike-protein (S-protein) interacts with the human cells through the host angiotensin-converting enzyme 2 (ACE2) receptor. However, the molecular mechanism of pathological mutations of S-protein is still unclear. In this perspective, we investigated the impact of mutations in the S-protein and their interaction with the ACE2 receptor for SAR-CoV-2 viral infection. We examined the stability of pathological nonsynonymous mutations in the S-protein, and the binding behavior of the ACE2 receptor with the S-protein upon nonsynonymous mutations using the molecular docking and MM_GBSA approaches. Using the extensive bioinformatics pipeline, we screened the destabilizing (L8V, L8W, L18F, Y145H, M153T, F157S, G476S, L611F, A879S, C1247F, and C1254F) and stabilizing (H49Y, S50L, N501Y, D614G, A845V, and P1143L) nonsynonymous mutations in the S-protein. The docking and binding free energy (ddG) scores revealed that the stabilizing nonsynonymous mutations show increased interaction between the S-protein and the ACE2 receptor compared to native and destabilizing S-proteins and that they may have been responsible for the virulent high level. Further, the molecular dynamics simulation (MDS) approach reveals the structural transition of mutants (N501Y and D614G) S-protein. These insights might help researchers to understand the pathological mechanisms of the S-protein and provide clues regarding mutations in viral infection and disease propagation. Further, it helps researchers to develop an efficient treatment approach against this SARS-CoV-2 pandemic.
Keywords: ACE2 receptor; Binding affinity; Nonsynonymous mutations; SARS-CoV-2; Spike protein; Stability.
Copyright © 2021. Published by Elsevier Ltd.
Conflict of interest statement
We have no conflicts of interest to disclose.
Figures














Similar articles
-
Computational modeling of the effect of five mutations on the structure of the ACE2 receptor and their correlation with infectivity and virulence of some emerged variants of SARS-CoV-2 suggests mechanisms of binding affinity dysregulation.Chem Biol Interact. 2022 Dec 1;368:110244. doi: 10.1016/j.cbi.2022.110244. Epub 2022 Nov 3. Chem Biol Interact. 2022. PMID: 36336003 Free PMC article.
-
Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.Comput Biol Chem. 2022 Feb;96:107613. doi: 10.1016/j.compbiolchem.2021.107613. Epub 2021 Dec 1. Comput Biol Chem. 2022. PMID: 34896769 Free PMC article.
-
Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.J Cell Biochem. 2022 Jul;123(7):1207-1221. doi: 10.1002/jcb.30276. Epub 2022 May 27. J Cell Biochem. 2022. PMID: 35620980 Free PMC article.
-
Mutation informatics: SARS-CoV-2 receptor-binding domain of the spike protein.Drug Discov Today. 2022 Oct;27(10):103312. doi: 10.1016/j.drudis.2022.06.012. Epub 2022 Jul 3. Drug Discov Today. 2022. PMID: 35787481 Free PMC article. Review.
-
Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective.Mol Biol Rep. 2023 Mar;50(3):2713-2721. doi: 10.1007/s11033-022-08193-4. Epub 2022 Dec 23. Mol Biol Rep. 2023. PMID: 36562937 Free PMC article. Review.
Cited by
-
Structural and pKa Estimation of the Amphipathic HR1 in SARS-CoV-2: Insights from Constant pH MD, Linear vs. Nonlinear Normal Mode Analysis.Int J Mol Sci. 2023 Nov 10;24(22):16190. doi: 10.3390/ijms242216190. Int J Mol Sci. 2023. PMID: 38003380 Free PMC article.
-
Global landscape of SARS-CoV-2 mutations and conserved regions.J Transl Med. 2023 Feb 25;21(1):152. doi: 10.1186/s12967-023-03996-w. J Transl Med. 2023. PMID: 36841805 Free PMC article.
-
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants.BioDrugs. 2022 May;36(3):231-323. doi: 10.1007/s40259-022-00529-7. Epub 2022 Apr 27. BioDrugs. 2022. PMID: 35476216 Free PMC article. Review.
-
VOC-alarm: mutation-based prediction of SARS-CoV-2 variants of concern.Bioinformatics. 2022 Jul 11;38(14):3549-3556. doi: 10.1093/bioinformatics/btac370. Bioinformatics. 2022. PMID: 35640977 Free PMC article.
-
An Italian Single-Center Genomic Surveillance Study: Two-Year Analysis of SARS-CoV-2 Spike Protein Mutations.Int J Mol Sci. 2025 Aug 5;26(15):7558. doi: 10.3390/ijms26157558. Int J Mol Sci. 2025. PMID: 40806685 Free PMC article.
References
-
- World Health Organization . World Health Organization; 2020. Coronavirus Disease 2019 (COVID-19): Situation Report; p. 52.https://apps.who.int/iris/handle/10665/331476
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous